|Trade names Glurenorm|
Routes of administration Oral (tablets)
Molar mass 527.634 g/mol
ATC code A10BB08 (WHO)
CAS ID 33342-05-1
|AHFS/Drugs.com International Drug Names|
Legal status UK: POM (Prescription only) In general: ℞ (Prescription only)
Gliquidone (INN, sold under the trade name Glurenorm) is an anti-diabetic medication in the sulfonylurea class. It is classified as a second-generation sulfonylurea. It is used in the treatment of diabetes mellitus type 2. It is marketed by the pharmaceutical company Boehringer Ingelheim (Germany).
Gliquidone is fully metabolized by the liver. Its metabolites are excreted virtually completely with bile (even with long-term administration), thus allowing the use of medication in diabetic patients suffering from kidney disease and diabetic nephropathy.